Chia-Yen Lin

7PUBLICATIONS
18CO-AUTHORS
Epidemiological modellingPredictive and prognostic markersMedical infection agents (incl. prions)Palliative careMidwifery not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 10, 2025
Use of Sodium-Glucose Transport Protein 2 Inhibitors and the Incidence of Urolithiasis: A Multi-Database and Cross-Country Study in Patients With Type 2 Diabetes Mellitus.

Mu-Chi Chung, Chia-Yen Lin, Chao-Hsiang Chang

|Aug 07, 2024
Comparative analysis of novel hormonal agents in non-metastatic castration-resistant prostate cancer: A Taiwanese perspective.

Po-Chieh Huang, Li-Hua Huang, Cheng-Kuang Yang

|Jan 08, 2023
Impact of Clinicopathological Characteristics and Tissue Inhibitor of Metalloproteinase-3 Polymorphism Rs9619311 on Biochemical Recurrence in Taiwanese Patients with Prostate Cancer.

Chun-Yu Hsieh, Chia-Yen Lin, Shian-Shiang Wang

|Dec 11, 2022
Hospice Care Improves Patients' Self-Decision Making and Reduces Aggressiveness of End-of-Life Care for Advanced Cancer Patients.

Chun-Li Wang, Chia-Yen Lin, Shun-Fa Yang

|Dec 01, 2022
The prognostic impact of lymph node dissection for clinically node-negative upper urinary tract urothelial carcinoma in patients who are treated with radical nephroureterectomy.

Hsiang-Chen Hsieh, Chun-Li Wang, Chuan-Shu Chen

|Sep 28, 2021
Associations between LncRNA MALAT1 Polymorphisms and Lymph Node Metastasis in Prostate Cancer.

Ju-Chuan Hu, Shian-Shiang Wang, Ying-Erh Chou

Pageof 2

Frequent Collaborators

4 joint publications

Shun-Fa Yang

2 joint publications

Shian-Shiang Wang

1 joint publications

Chun-Li Wang

1 joint publications

Ju-Chuan Hu